Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection
about
Increased burst size in multiply infected cells can alter basic virus dynamicsModeling the within-host dynamics of HIV infectionPerspectives on the basic reproductive ratioHIV-1 eradication strategies: design and assessmentNonpathogenic simian immunodeficiency virus infectionsContribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapyA tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessationBiologically-directed modeling reflects cytolytic clearance of SIV-infected cells in vivo in macaquesRapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaquesModeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsModeling the Effects of Morphine on Simian Immunodeficiency Virus DynamicsComparative estimation of the reproduction number for pandemic influenza from daily case notification data.Nanostructured optical photonic crystal biosensor for HIV viral load measurement.Competition-colonization trade-off promotes coexistence of low-virulence viral strainsImproving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model.Going wild: lessons from naturally occurring T-lymphotropic lentivirusesEstimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection.Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system.CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques.Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenDivergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hostsPathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 InfectionsEffect of the initial dose of foot-and-mouth disease virus on the early viral dynamics within pigs.An accurate two-phase approximate solution to an acute viral infection modelResolving the impact of waiting time distributions on the persistence of measlesImpact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatmentViral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia.Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatmentShort- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replicationSimian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.Stochastic theory of early viral infection: continuous versus burst production of virions.Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity.Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
P2860
Q21203747-A79CB849-DC82-4A52-B5D6-2293936A2775Q21245370-6D441FE2-BE8D-450F-9EFB-C79ACF938EECQ24669998-6C0F4FFE-A0C7-4D6D-BEE7-72B8BEBC30B8Q26864933-2339C6D7-5D7E-4DC6-AB9B-E40987557DF7Q27004065-34356A82-1FFC-4066-AE5E-83FF51370253Q27309008-5450B2F9-49E9-49EB-9846-B835136AAF14Q27313556-0A1F3615-C216-401A-9969-A51986FDB67EQ27319650-A6A3F31B-D459-4FC9-B387-98FE4B367F6AQ27319762-F9EBFB35-4834-49C6-9A85-16EF6DF0D572Q27469340-50E2BF7D-42DD-44E5-BF63-4FF8FE3729FCQ28551803-A9ED3DA5-F13E-4379-AFA7-9AEECCE3A331Q28554352-4EE79FCA-4B43-4FA8-9BD2-064471608CA6Q30359451-6A217030-ADCE-4BB4-82AA-DE90F07CD97EQ30442145-22CD09A7-5DF3-4797-BB88-DEFA8B47521BQ30522555-1CC446DB-AD9F-4BC5-B5B4-775B438F867CQ30828221-E9A6E25A-A327-4219-89DA-5C4BFCCD3461Q31066870-FDA4A246-B14F-41FA-838A-6914A4269AFEQ33239376-2A35AAAD-B118-423B-BABC-71F381C35E6EQ33564308-A92098CD-CE90-4F84-A36B-24FBA1E028F7Q33618007-4BCC7AAD-1F15-417C-BFD0-358746C3741DQ33618013-82E490B3-98DD-4023-ADFF-69BD05F6430AQ33640139-B2016016-DDEE-4451-B0CC-37AEA315D4FCQ33643898-61246B31-0584-4FF4-8B0E-08A114EB017CQ33649842-E9ED9B6B-4793-4CA1-A67E-20077BD42890Q33707549-5C5BFA30-E438-4D62-9FA3-E64B36548CB6Q33715552-EBAAD605-EB3B-4103-89D9-0C850810A03DQ33726687-AFD0B8C0-C3CE-4532-893F-B97EC39AA65EQ33739420-E33A81CB-F0E1-4797-8868-0ECF16EFF34EQ33743273-D25C61AA-FDC1-46AD-9E4E-A40F8D269042Q33780668-1736807D-F781-4C08-B8BE-98FCA76F3956Q33782843-794485BD-5C05-4B64-A78F-7084E8F1DB31Q33783429-76D13ED9-5E7A-4E6A-BDCC-7CACFBB12FC8Q33786257-5794BFC1-1A53-4F2B-B77A-9DD3FFBF8D33Q33799700-5D4AC1F4-D252-405A-ADE5-F7568AF8BFC7Q33808774-C4071EFF-E91B-4A6D-B886-252E8F67ED97Q33811266-A9D7A57F-CE36-44FF-9686-5FFAED359821Q33813926-80EB62D1-178F-4E8B-940B-3E419D0CF9A2Q33815539-C2463579-876B-4BFD-8EB9-61819753FC87Q33826587-73E03868-3BF4-4D2D-B916-60424346AFA8Q33847673-419D45B5-EA4E-4188-B239-FC5F9E96610F
P2860
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Viral dynamics of primary vire ...... munodeficiency virus infection
@ast
Viral dynamics of primary vire ...... munodeficiency virus infection
@en
type
label
Viral dynamics of primary vire ...... munodeficiency virus infection
@ast
Viral dynamics of primary vire ...... munodeficiency virus infection
@en
prefLabel
Viral dynamics of primary vire ...... munodeficiency virus infection
@ast
Viral dynamics of primary vire ...... munodeficiency virus infection
@en
P2093
P2860
P1433
P1476
Viral dynamics of primary vire ...... munodeficiency virus infection
@en
P2093
G M Vasquez
J D Lifson
J Williams
N Bischofberger
T A Wiltrout
V M Hirsch
P2860
P304
P407
P577
1997-10-01T00:00:00Z